Is Pitolisant a self-paid drug or a medically insured drug?

Pitolisant (Pitolisant) has been officially launched in China and has been included in the medical insurance catalog, becoming the first-line targeted drug for the treatment of narcolepsy (Narcolepsy). After being included in medical insurance, patients who meet the reimbursement conditions can reduce part of their financial burden through medical insurance, making treatment more accessible.

The domestic original drug specification is 4.5mg*30 tablets, and the price per box is about 1,000 RMB. Due to medical insurance coverage, the patient's actual out-of-pocket amount will vary according to local medical insurance policies, and is usually much lower than the original price, which is helpful for long-term regular medication use. Hospital pharmacies and medical insurance designated pharmacies are formal channels for purchasing medicines, ensuring safe and reliable sources of medicines.

In overseas markets, tilorisen has also been launched, and generic drugs are also available. For example, a generic drug produced by a Lao pharmaceutical factory with a specification of 18mg*30 tablets sells for about 3,000 yuan per box. The ingredients of the drug are basically the same as the original drug, but the price is relatively higher than the out-of-pocket price after reimbursement by domestic medical insurance, and the drug must be purchased through formal overseas channels and in compliance with import regulations.

Generally speaking, tilorisen is a medical insurance drug in the country, rather than a completely self-paid drug. Patients should follow the doctor's guidance when using it, choose regular channels to purchase medicines, and pay attention to medical insurance policies and reimbursement ratios to ensure long-term, sustained, and safe treatment effects, and regularly review the efficacy and adverse reactions during use.

Reference materials:https://www.drugs.com/

xa0